Bipartisan Bill Would Unlock User Fees For Drugs, Devices
Bipartisan legislation introduced Thursday in Congress would prevent sequestration from applying to user fees that pharmaceutical and medical device firms pay to fund regulatory approvals, a breakthrough for corporations arguing that...To view the full article, register now.
Already a subscriber? Click here to view full article